News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
India’s Ranbaxy Laboratories Recalls Gabapentin Tablets in U.S.
November 16, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MUMBAI, Nov 16 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd (RANB.BO: Quote, Profile, Research) is recalling some gabapentin tablets in the United States, a spokesman said, confirming a report in the Economic Times on Friday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Asia
MORE ON THIS TOPIC
HIV
Gilead Looks To Simplify HIV Treatment By Combining Two Leading Drugs in One Pill
November 14, 2025
·
2 min read
·
Tristan Manalac
RNA editing
Korro Suffers Cacophony of Bad News as Lead Candidate Fails, Novo Pauses RNA Deal
November 13, 2025
·
3 min read
·
Annalee Armstrong
Obesity
Zealand Freezes Mid-Stage Obesity Asset To Focus on More Differentiated Drugs
November 13, 2025
·
2 min read
·
Tristan Manalac
Neuroscience
Alkermes Pushes Narcolepsy Program to Phase III With ‘Highly Competitive’ Mid-Stage Data
November 13, 2025
·
2 min read
·
Tristan Manalac
